Table 1 Outcomes and outcome-related indicators of all study participants by gender
Characteristics | Male | Female | Overall | P |
|---|---|---|---|---|
N (%) | N (%) | N (%) | ||
The prevalence of MetS | 1105(48.1) | 1391(43.7) | 249(45.6) | 0.001 |
WC (cm) | 89.000 (81.000–97.000) | 82.000 (71.925–91.000) | 85.000 (76.000–94.000) |  < 0.001 |
Weight (kg) | 73.400 (66.000–81.750) | 62.000 (56.900–69.400) | 67.000 (59.000–75.000) |  < 0.001 |
Height (cm) | 170.000 (165.000–174.000) | 158.500 (155.000–163.000) | 163.000 (157.000–169.000) |  < 0.001 |
TG (mg/dL) | 124.889 (82.374–190.434) | 107.174 (79.952–158.547) | 113.375 (77.945–170.062) |  < 0.001 |
TC (mg/dL) | 194.122 (168.987–220.418) | 197.602 (172.854–227.475) | 195.669 (170.534–224.671) | 0.001 |
HDL-C (mg/dL) | 50.271 (43.310–59.551) | 57.231 (49.111–66.222) | 54.138 (46.404–64.192) |  < 0.001 |
LDL-C (mg/dL) | 119.490 (98.801–141.145) | 117.169 (97.448–140.371) | 117.943 (98.221–140.758) |  < 0.001 |
FBG (mg/dL) | 102.600 (93.600–117.000) | 100.800 (93.600–113.400) | 102.600 (93.600–115.200) |  < 0.001 |
SBP (mmHg) | 132.000 (120.000–143.000) | 128.000 (115.00–143.000) | 130.000 (118.000–142.000) |  < 0.001 |
DBP (mmHg) | 86.00 (78.00–93.00) | 81.00 (74.00–89.00) | 83.00 (75.00–91.00) |  < 0.001 |